Peer support site for tapering psychiatric drugs & recovery from withdrawal. Advocating non-drug strategies for mental health. AKA @Altostrata #Deprescribing
Joined May 2011
- Tweets9K
- Following408
- Followers988
- Likes155
Pinned Tweet
Hello -- Will be tweeting about #Deprescribing from @Altostrata account. If you are interested in #psychiatric #deprescribing, please follow @Altostrata. Will use this account for tweets about my Web site, SurvivingAntidepressants.org
WEBINAR Monday, July 28, 2025 Hyperbolic tapering tips: Barriers and enablers with Mark Horowitz, MBBS, PhD - Events, actions, controversies - Surviving Antidepressants survivingantidepressants.org…
46
Surviving ADs retweeted
@dropthedisorder @PsychSIGN @PsychiatristsCA @BasedPsychMD @Institute_PDW @MedicatingNorm1 @Mad_In_America @angpeacock1111 @SurvivingADs @DeprescribeNet @DeprescribeUS @BenzoReform
Presenting a WEBINAR:
Hyperbolic tapering tips: Barriers and enablers
with Mark Horowitz, MBBS, PhD
lead author of the 2024 Maudsley Deprescribing Guidelines
Monday, July 28, 2025
10-11 am PST | 1-2 p.m EST | 5-6 pm GMT
RSVP today! Donation requested.
psychdeprescribing.org/index…
Hello -- Who is leading Antidepressant Withdrawal Australia? Please contact me.
Antidepressant Withdrawal Australia 2025 - Lived Experience 8 mins youtu.be/HnG6om8ufrQ?si=EVJo… via @YouTube
2
2
135
Surviving ADs retweeted
A Relationship Imbalance, Not A Chemical Imbalance
by Amy Begel
With DSM-III, everything we knew about relationship dynamics was buried under the tidal wave of the pharmaceutical industrial complex.
madinamerica.com/2025/06/a-r…
Surviving ADs retweeted
Researchers: “We Do Not Suggest” Antipsychotics for Depression
Augmenting with antipsychotics was no better at reducing suicide than adding antidepressants, but led to increased risk of death from other causes.
By Peter Simons
buff.ly/ooq0en4
Surviving ADs retweeted
How to define behavioral addictions such as problematic social media use, so that we don't pathologise normal behavior but also don't miss clearly dysfunctional investment? According to our new paper the harmful dysfunction analysis is a promising avenue:
tandfonline.com/doi/full/10.…
How about that? Total views and downloads: 152977
This Post is from a suspended account. Learn more
2
104
Surviving ADs retweeted
My psychiatrist would have said the same thing; I just needed to take an AD, it's relapse. Antidepressant withdrawal is mild and self-limiting as per industry-biased medicine. Other psychotropics can cause protracted withdrawal, so why not the ADs?
psychologytoday.com/us/blog/…
Surviving ADs retweeted
"People who stop taking antidepressants can experience lingering withdrawal symptoms that last months or even years, according to a new study published in the journal 'Epidemiology and Psychiatric Sciences.'"
#MentalHealth #antidepressants
LINK: psypost.org/antidepressant-w…
Surviving ADs retweeted
Really important conversation and initiative. Morgan is inspiring in turning her story of harm into a campaign to stop this happening to others. Please support her. Terribly sad that it is left to harmed patients to make changes given so much denial from doctors.
NEW VIDEO UPLOAD ON THE MEDICATING NORMAL YOUTUBE CHANNEL:
A Conversation With Morgan Stewart, founder of the Antidepressant Coalition for Education
@ACE_CoalitionEd
LINK TO WATCH INTERVIEW: youtu.be/4qGHoLaNiJ8
Bio: Morgan Stewart founded the nonprofit Antidepressant Coalition for Education (ACE) in response to the clear demand for an organization dedicated to awareness, education, and research on the adverse effects of antidepressants. She was called to this work after enduring a traumatic withdrawal from an SSRI in 2022.
You can find ACE at antidepressantinfo.org
WE NEED YOUR HELP!!
✅ TWO ACTION ITEMS
📢 Comment on the FDA Petition:
buff.ly/c62aqgz
📝 Report Your Harm via FDA’s MedWatch Program:
buff.ly/32rc8JE
📧 Need help reporting? Email ACE:
[email protected]
(See the description box under the video on YouTube for more information and links. And please make sure to subscribe to our YouTube channel and "Like" and share our content so we can continue to educate and spread awareness!)
#MentalHealth #antidepressants
What a shame we cannot beat the brain into submission with drugs. Those stubborn brains. If it weren't for them, psychopharmacology would be easy.
Medications are often blamed when tolerance or side effects emerge.
But the issue may be the brain’s natural effort to balance itself in the presence of a persistent external input.
🧵12/15
24
Surviving ADs retweeted
"Maternal-Fetal Medicine expert Dr. Adam Urato delivers a critical warning about the rising use of SSRIs (antidepressants) during pregnancy—and the serious risks they pose to both mother and child."
@AdamUrato1
#antidepressants #pregnancy
thehighwire.com/ark-videos/t…
Surviving ADs retweeted
Join us June 20 for a free Zoom training on benzo harms, physical dependence & tapering—led by our Medical Director, Nicole Lamberson, PA. Open to all, provider-focused. Q&A prioritizes clinician questions.
RSVP: [email protected] or scan the flyer QR.
Would anyone be able to share this paper? Pruskowski, J. A., et al. (2021). How to implement deprescribing into clinical practice. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 4(10), 1348–1357. doi.org/10.1002/jac5.1521
19
Surviving ADs retweeted
"Our findings highlight the need for careful monitoring of metabolic health in patients prescribed antidepressants."
Article Link: buff.ly/48lcni8
Surviving ADs retweeted
Joining us on our #podcast is Dr Paul Andrews. His research focuses on understanding the evolution of #depression, which he argues may be an evolved emotional response for understanding and solving complex problems. #psychology #evolution #mentalhealth
madinamerica.com/2024/10/we-…
Surviving ADs retweeted
A new syst. review (29 RCTs) & meta-analysis (20 RCTs) assesses the effectiveness of psychotropic meds, incl. antidepressants & gabapentinoids, in the management of specific chronic pain conditions (fibromyalgia, neuropathic pain, and chronic lower back pain).
Key findings:
- Only duloxetine & mirogabalin were effective for short-term (<14 weeks) pain management of fibromyalgia, but not neuropathic and chronic lower back pains
- Psychotropic meds had no significant benefits for long-term (>14 weeks) pain management
- Insufficient RCT data to evaluate the effectiveness of gabapentin for chronic pain management, or pregabalin for neuropathic pain
Further evidence to integrating both pharmacological & non-pharmacological strategies and #deprescribing when meds have few benefits & increase the risk of harm (e.g., weight gain, sexual dysfunction, or cognitive issues)
shorturl.at/H6lEF
@FrontPain @HansiniKochhar @Bk__ghosh @MichaelHsuMD @berardis_de @SuryaKarlapati
Surviving ADs retweeted
Great that @rcpsych has put out a CPD podcast about hyperbolic tapering/deprescribing with Prof Taylor @DavidTa23968240 and myself. Hopefully it will become embedded as a core skill. A few further developments are likely to help push this out in the NHS as a whole too....
This quoted post is unavailable.
Surviving ADs retweeted
Researchers Accuse Lancet Article and British Psychiatrists of Minimising Antidepressants’ Withdrawal Effects
by John Read
A response to a seriously flawed review, which received uncritical attention from the British and international media.
madinamerica.com/2024/09/res…
